135 related articles for article (PubMed ID: 27444341)
1. Identification of a novel BCL2-specific inhibitor that binds predominantly to the BH1 domain.
Iyer D; Vartak SV; Mishra A; Goldsmith G; Kumar S; Srivastava M; Hegde M; Gopalakrishnan V; Glenn M; Velusamy M; Choudhary B; Kalakonda N; Karki SS; Surolia A; Raghavan SC
FEBS J; 2016 Sep; 283(18):3408-37. PubMed ID: 27444341
[TBL] [Abstract][Full Text] [Related]
2. Novel BCL2 inhibitor, Disarib induces apoptosis by disruption of BCL2-BAK interaction.
Vartak SV; Iyer D; Santhoshkumar TR; Sharma S; Mishra A; Goldsmith G; Srivastava M; Srivastava S; Karki SS; Surolia A; Choudhary B; Raghavan SC
Biochem Pharmacol; 2017 May; 131():16-28. PubMed ID: 28223017
[TBL] [Abstract][Full Text] [Related]
3. A novel inhibitor of BCL2, Disarib abrogates tumor growth while sparing platelets, by activating intrinsic pathway of apoptosis.
Vartak SV; Hegde M; Iyer D; Gaikwad S; Gopalakrishnan V; Srivastava M; Karki SS; Choudhary B; Ray P; Santhoshkumar TR; Raghavan SC
Biochem Pharmacol; 2016 Dec; 122():10-22. PubMed ID: 27693384
[TBL] [Abstract][Full Text] [Related]
4. Acute toxicity analysis of Disarib, an inhibitor of BCL2.
Sharma S; Varsha KK; Kumari S; Gopalakrishnan V; Jose AE; Choudhary B; Mantelingu K; Raghavan SC
Sci Rep; 2020 Sep; 10(1):15188. PubMed ID: 32938954
[TBL] [Abstract][Full Text] [Related]
5. Acute toxicity analysis of an inhibitor of BCL2, Disarib, in rats.
Sharma S; Varsha KK; Ray U; Siddiqua H; Jose AE; Muninarasimaiah S; Raghavan SC; Choudhary B
Sci Rep; 2021 May; 11(1):9982. PubMed ID: 33976278
[TBL] [Abstract][Full Text] [Related]
6. Indole-coumarin-thiadiazole hybrids: An appraisal of their MCF-7 cell growth inhibition, apoptotic, antimetastatic and computational Bcl-2 binding potential.
Kamath PR; Sunil D; Joseph MM; Abdul Salam AA; T T S
Eur J Med Chem; 2017 Aug; 136():442-451. PubMed ID: 28525842
[TBL] [Abstract][Full Text] [Related]
7. Progress in BCL2 inhibition for patients with chronic lymphocytic leukemia.
Tam CS; Seymour JF; Roberts AW
Semin Oncol; 2016 Apr; 43(2):274-9. PubMed ID: 27040706
[TBL] [Abstract][Full Text] [Related]
8. Efficient T3P
Kamath PR; Sunil D; Das S; Abdul Salam AA; Rao BS
Chem Biol Interact; 2017 Apr; 268():53-67. PubMed ID: 28235427
[TBL] [Abstract][Full Text] [Related]
9. Cap-translation inhibitor, 4EGI-1, restores sensitivity to ABT-737 apoptosis through cap-dependent and -independent mechanisms in chronic lymphocytic leukemia.
Willimott S; Beck D; Ahearne MJ; Adams VC; Wagner SD
Clin Cancer Res; 2013 Jun; 19(12):3212-23. PubMed ID: 23633452
[TBL] [Abstract][Full Text] [Related]
10. Targeting BCL2 With BH3 Mimetics: Basic Science and Clinical Application of Venetoclax in Chronic Lymphocytic Leukemia and Related B Cell Malignancies.
Roberts AW; Huang D
Clin Pharmacol Ther; 2017 Jan; 101(1):89-98. PubMed ID: 27806433
[TBL] [Abstract][Full Text] [Related]
11. Bcl2L12 with a BH3-like domain in regulating apoptosis and TMZ-induced autophagy: a prospective combination of ABT-737 and TMZ for treating glioma.
Yang MC; Loh JK; Li YY; Huang WS; Chou CH; Cheng JT; Wang YT; Lieu AS; Howng SL; Hong YR; Chou AK
Int J Oncol; 2015 Mar; 46(3):1304-16. PubMed ID: 25586056
[TBL] [Abstract][Full Text] [Related]
12. Benzylamide sulindac analogues induce changes in cell shape, loss of microtubules and G(2)-M arrest in a chronic lymphocytic leukemia (CLL) cell line and apoptosis in primary CLL cells.
Moon EY; Lerner A
Cancer Res; 2002 Oct; 62(20):5711-9. PubMed ID: 12384529
[TBL] [Abstract][Full Text] [Related]
13. ABT-737 resistance in B-cells isolated from chronic lymphocytic leukemia patients and leukemia cell lines is overcome by the pleiotropic kinase inhibitor quercetin through Mcl-1 down-regulation.
Russo M; Spagnuolo C; Volpe S; Tedesco I; Bilotto S; Russo GL
Biochem Pharmacol; 2013 Apr; 85(7):927-36. PubMed ID: 23353698
[TBL] [Abstract][Full Text] [Related]
14. The investigational agent MLN2238 induces apoptosis and is cytotoxic to CLL cells in vitro, as a single agent and in combination with other drugs.
Paulus A; Masood A; Miller KC; Khan AN; Akhtar D; Advani P; Foran J; Rivera C; Roy V; Colon-Otero G; Chitta K; Chanan-Khan A
Br J Haematol; 2014 Apr; 165(1):78-88. PubMed ID: 24467634
[TBL] [Abstract][Full Text] [Related]
15. Integrated Transcriptome and Metabolomic Analysis Reveal Anti-Angiogenic Properties of Disarib, a Novel Bcl2-Specific Inhibitor.
Manjunath M; Swaroop S; Pradhan SS; Rao K R; Mahadeva R; Sivaramakrishnan V; Choudhary B
Genes (Basel); 2022 Jul; 13(7):. PubMed ID: 35885991
[TBL] [Abstract][Full Text] [Related]
16. Peptide screening to knockdown Bcl-2's anti-apoptotic activity: implications in cancer treatment.
Raghav PK; Verma YK; Gangenahalli GU
Int J Biol Macromol; 2012 Apr; 50(3):796-814. PubMed ID: 22155216
[TBL] [Abstract][Full Text] [Related]
17. Molecular targeting of BCL2 and BCLXL proteins by synthetic BCL2 homology 3 domain peptide enhances the efficacy of chemotherapy.
Dharap SS; Chandna P; Wang Y; Khandare JJ; Qiu B; Stein S; Minko T
J Pharmacol Exp Ther; 2006 Mar; 316(3):992-8. PubMed ID: 16291730
[TBL] [Abstract][Full Text] [Related]
18. Selective targeting of BCL6 induces oncogene addiction switching to BCL2 in B-cell lymphoma.
Dupont T; Yang SN; Patel J; Hatzi K; Malik A; Tam W; Martin P; Leonard J; Melnick A; Cerchietti L
Oncotarget; 2016 Jan; 7(3):3520-32. PubMed ID: 26657288
[TBL] [Abstract][Full Text] [Related]
19. A synthetic peptide targeting the BH4 domain of Bcl-2 induces apoptosis in multiple myeloma and follicular lymphoma cells alone or in combination with agents targeting the BH3-binding pocket of Bcl-2.
Lavik AR; Zhong F; Chang MJ; Greenberg E; Choudhary Y; Smith MR; McColl KS; Pink J; Reu FJ; Matsuyama S; Distelhorst CW
Oncotarget; 2015 Sep; 6(29):27388-402. PubMed ID: 26317541
[TBL] [Abstract][Full Text] [Related]
20. Upregulation of bfl-1 is a potential mechanism of chemoresistance in B-cell chronic lymphocytic leukaemia.
Olsson A; Norberg M; Okvist A; Derkow K; Choudhury A; Tobin G; Celsing F; Osterborg A; Rosenquist R; Jondal M; Osorio LM
Br J Cancer; 2007 Sep; 97(6):769-77. PubMed ID: 17726463
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
